Abstract:Main observation and conclusion Psoriasis is a chronic immune‐mediated inflammatory skin disease and the TNF‐α is an important therapeutic target of this disease. In our continuous study of bioactive natural products from fungi, the first ergosterol‐polyether adducts, polyaspers A (1) and B (2), along with two known ergosterols, (3β,5α,6α,22E)‐5,6‐epoxy‐3‐hydroxyergosta‐8,22‐dien‐7‐one (3) and calvasterol B (4), were isolated from Aspergillus sp. TJ507. Structure elucidation was accomplished by extensive spectroscopic analysis and single‐crystal X‐ray diffraction tests. Polyaspers A and B possessing an unequalled 6/6/6/5/5/6/6/6/6 nonacyclic system, and their biosynthetic pathways were proposed to include intermolecular cyclization and Diels‐Alder reactions. Activity screen of these isolates showed that 1−3 could improve the cell viability in an actinomycin D/TNF‐α induced L929 cells death model, with the EC50 values ranging from 49.85, 46.75 and 4.99 μM, respectively, and the activity of 3 was even comparable with that of the positive control SPD304. Further bioactive investigations discovered 3 could suppress the inflammatory response simulated with TNF‐α in HaCaT cells. In an imiquimod‐induced psoriasis murine model, 3 significantly restrained the development of psoriasis symptoms and reduced the expression of IL‐17 and IL‐23, that presenting an anti‐psoriatic effect. As such, those ergosterol derivatives, might serve as lead structures for the development of novel TNF‐α inhibitory agents in the clinical treatment of psoriasis. This article is protected by copyright. All rights reserved.

Spirohypertones A and B As Potent Antipsoriatics: Tumor Necrosis Factor-Α Inhibitors with Unprecedented Chemical Architectures

Polyaspers A and B, the first ergosterol‐polyether adducts with unprecedented 6/6/6/5/5/6/6/6/6 nonacyclic architecture from Aspergillus sp. TJ507

Structure-Based Drug Design and Synthesis of Pyrrolidine-2,5-diones as Novel TNF-α Inhibitors

Antitumor Agents 268. Design, Synthesis, and Mechanistic Studies of New 9-Substituted Phenanthrene-Based Tylophorine Analogues As Potent Cytotoxic Agents.

Absolute Configuration and Biological Evaluation of Novel Triterpenes as Possible Anti-Inflammatory or Anti-Tumor Agents

Discovery of bioactive polycyclic polyprenylated acylphloroglucinols with adamantine/homoadamantane skeletons from Hypericum wilsonii

Hyperispirones A and B, spiro-bridged polycyclic polyprenylated acylphloroglucinols with anti-angiogenesis activity from <i>Hypericum beanii</i>

Hyperinoids A and B, Two Polycyclic Meroterpenoids from Hypericum Patulum

Longisglucinols A–C, Structurally Intriguing Polycyclic Polyprenylated Acylphloroglucinols with Anti-inflammatory Activity from Hypericum longistylum

Hypersubones A and B, New Polycyclic Acylphloroglucinols with Intriguing Adamantane Type Cores from Hypericum subsessile

Discovery of 13,15-nor-polycyclic Polyprenylated Acylphloroglucinols from Hypericum Longistylum with Anti-Inflammatory Activity.

Discovery of an Orally Active Small-Molecule Tumor Necrosis Factor-α Inhibitor

Discovery of Undescribed Monoterpenoid Polyprenylated Acylphloroglucinols with Immunosuppressive Activities from Hypericum longistylum

Kiiacylphnols A−H, eight undescribed polycyclic polyprenylated acylphloroglucinols with anticancer activities from Hypericum przewalskii Maxim

Hyparillums A and B: polycyclic polyprenylated acylphloroglucinols from Hypericum patulum

Hyperhenrones: Prenylated α-pyrones with anti-inflammatory activity from Hypericum henryi

Two new acorane-type sesquiterpenoids from an endophytic Trichoderma harzianum associated with Paeonia lactiflora Pall

Tiamulin Inhibits TNF-α and Alleviates Psoriasis-Like Dermatitis.

Discovery of Highly Potent Tnf Alpha Inhibitors Using Virtual Screen

Discovery of Cyclic Peptide Inhibitors Targeted on TNFα-TNFR1 from Computational Design and Bioactivity Verification

Synthesis and biological evaluation of new C-10 substituted dithranol pleiotropic hybrids